AVR

Anteris Technologies Global Corp

Sep 16 • 04:00PM ET

5.71

-0.11 -1.89 %

Healthcare • Medical Instruments & Supplies • USA • NASD

Held by: IWM IWO VXF VTWO IWC VTWG RSSL URTY UWM ITWO

Index	RUT	P/E	-	EPS (ttm)	-2.33	Insider Own	0.21%	Shs Outstand	36.06M	Perf Week	23.06%
Market Cap	205.91M	Forward P/E	-	EPS next Y	-1.95	Insider Trans	0.00%	Shs Float	35.99M	Perf Month	41.34%
Enterprise Value	179.91M	PEG	-	EPS next Q	-0.54	Inst Own	47.50%	Short Float	2.30%	Perf Quarter	42.39%
Income	-83.93M	P/S	83.03	EPS this Y	39.36%	Inst Trans	-8.43%	Short Ratio	4.34	Perf Half Y	-15.03%
Sales	2.48M	P/B	8.44	EPS next Y	12.74%	ROA	-296.17%	Short Interest	0.83M	Perf YTD	2.33%
Book/sh	0.68	P/C	7.24	EPS next 5Y	19.87%	ROE	-615.48%	52W High	8.79 -35.04%	Perf Year	-
Cash/sh	0.79	P/FCF	-	EPS past 3/5Y	-57.99% -	ROIC	-321.01%	52W Low	2.34 144.02%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-8.10% -	Gross Margin	8.38%	Volatility	12.34% 10.51%	Perf 5Y	-
Dividend TTM	-	EV/Sales	72.55	EPS Y/Y TTM	-40.08%	Oper. Margin	-3419.78%	ATR (14)	0.45	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.38	Sales Y/Y TTM	-2.44%	Profit Margin	-3385.59%	RSI (14)	75.42	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.41	EPS Q/Q	-10.99%	SMA20	32.01%	Beta	-	Target Price	13.84
Payout	-	Debt/Eq	0.12	Sales Q/Q	-2.14%	SMA50	51.52%	Rel Volume	1.38	Prev Close	5.82
Employees	136	LT Debt/Eq	0.07	Earnings	Aug 11 AMC	SMA200	18.21%	Avg Volume	190.55K	Price	5.71
IPO	Dec 13, 2024	Option/Short	No / Yes	EPS/Sales Surpr.	-6.42% 54.50%	Trades		Volume	262,784	Change	-1.89%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-08-25	Initiated	Lake Street	Buy	$20
Jan-07-25	Initiated	TD Cowen	Buy	$15
Jan-07-25	Initiated	Cantor Fitzgerald	Overweight	$9
Jan-07-25	Initiated	Barclays	Overweight	$22

Sep-11-25 08:50AM	Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders (GlobeNewswire)
Sep-04-25 01:42AM	Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders (GlobeNewswire)
Aug-11-25 04:52PM	Anteris Announces Results for the Second Quarter of 2025 (GlobeNewswire) +6.00%
Jul-29-25 10:23AM	Anteris (AVR) Welcomes Two Directors as Major Trial Approaches (Insider Monkey)
Jun-09-25 10:52PM	Anteris Appoints David Roberts and Gregory Moss to its Board of Directors (GlobeNewswire) +13.29%
05:45PM	Loading…
May-13-25 05:45PM	Anteris Announces Results for the First Quarter of 2025 (GlobeNewswire) -9.89%
Mar-31-25 07:15AM	Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR THV (GlobeNewswire)
Mar-21-25 07:30AM	Anteris Reports One-Year Patient Outcomes for DurAVR THV (GlobeNewswire) -10.16%
Mar-12-25 08:33PM	Anteris Reports 2024 Financial Results and Provides Corporate Update (GlobeNewswire) -6.18%
Feb-28-25 08:00AM	Anteris to Present at Healthcare Investor Conferences - TD Cowen and Barclays (GlobeNewswire)
Dec-16-24 07:49PM	Anteris Technologies Global Corp. Announces Closing of $88.8 Million U.S. Initial Public Offering (Business Wire)
Dec-12-24 10:34PM	Anteris Technologies Global Corp. Announces Pricing of U.S. Initial Public Offering (Business Wire)

Anteris Technologies Global Corp. is a structural heart company, which engages in the development and commercialization of medical devices for heart diseases. It operates through the following geographical segments: United States, Germany, Australia, Switzerland, and Sweden. The company was founded in 1999 and is headquartered in Eagan, MN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Seaberg John D	Director	Mar 06 '25	Option Exercise	7.13	40,000	285,200	40,000	Mar 20 07:43 PM
Paterson Wayne	Chief Executive Officer	Mar 05 '25	Option Exercise	7.13	233,000	1,661,290	233,000	Mar 20 07:40 PM
Denaro Stephen	Director	Mar 11 '25	Option Exercise	7.13	16,500	117,645	23,722	Mar 20 07:35 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AVR

Anteris Technologies Global Corp

Upgrade your FINVIZ experience